Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycin.

× No keyword cloud information.

21 in total

Review 1. A prolonged QTc interval. Is it an important effect of antiarrhythmic drugs?

Authors: F A Fish; D M Roden
Journal: Med Toxicol Adverse Drug Exp Date: 1989 Nov-Dec

2. Cardiovascular and autonomic pharmacology of the macrolide antibiotic LY281389 in anesthetized beagles and in isolated smooth and cardiac muscles.

Authors: W E Colbert; J A Turk; P D Williams; M K Buening
Journal: Antimicrob Agents Chemother Date: 1991-07 Impact factor: 5.191

3. Association of intravenous erythromycin and potentially fatal ventricular tachycardia with Q-T prolongation (torsades de pointes).

Authors: R A Schoenenberger; W E Haefeli; P Weiss; R F Ritz
Journal: BMJ Date: 1990-05-26

4. Comparative pharmacodynamic analysis of Q-T interval prolongation induced by the macrolides clarithromycin, roxithromycin, and azithromycin in rats.

Authors: H Ohtani; C Taninaka; E Hanada; H Kotaki; H Sato; Y Sawada; T Iga
Journal: Antimicrob Agents Chemother Date: 2000-10 Impact factor: 5.191

Review 5. Drug effects on the electrocardiogram. A review of their clinical importance.

Authors: J D Symanski; L S Gettes
Journal: Drugs Date: 1993-08 Impact factor: 9.546

Review 6. [Proarrhythmic adverse effects of nonarrhythmic drugs].

Authors: C G Jungbauer; L S Maier
Journal: Herzschrittmacherther Elektrophysiol Date: 2019-08-23

Review 7. Cardiovascular safety of prokinetic agents: A focus on drug-induced arrhythmias.

Authors: J R Giudicessi; M J Ackerman; M Camilleri
Journal: Neurogastroenterol Motil Date: 2018-02-14 Impact factor: 3.598

8. Characterization of the inhibitory effects of erythromycin and clarithromycin on the HERG potassium channel.

Authors: Scott J C Stanat; Carol G Carlton; William J Crumb; Krishna C Agrawal; Craig W Clarkson
Journal: Mol Cell Biochem Date: 2003-12 Impact factor: 3.396

Review 9. Possible risk for cardiac arrhythmia related to intravenous erythromycin.

Authors: W E Haefeli; R A Schoenenberger; P Weiss; R Ritz
Journal: Intensive Care Med Date: 1992 Impact factor: 17.440

Review 10. QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards.

Authors: M Zehender; S Hohnloser; H Just
Journal: Cardiovasc Drugs Ther Date: 1991-04 Impact factor: 3.727